Skip to main content
Cancer Biotherapy & Radiopharmaceuticals logoLink to Cancer Biotherapy & Radiopharmaceuticals
. 2009 Apr 1;24(2):287. doi: 10.1089/cbr.2009.C242

Corrections

PMCID: PMC4990010

The paper entitled “Protein- and DNA-Based Active Immunotherapy Targeting Interleukin-13 Receptor Alpha2,” in 2008;23(5):581–589; doi: 10.1089/cbr.2008.0462, was missing important Acknowledgements. They are as follows:

Acknowledgments

This work was performed in the laboratory of Waldemar Debinski, M.D., Ph.D., and sponsored by National Cancer Institute grant number R01 CA 74145.

The Publisher and the authors apologize for any inconvenience these errors may have caused.


Articles from Cancer Biotherapy & Radiopharmaceuticals are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES